Noticias y eventos de Arbutus Biopharma Corp (ABUS)ABUSArbutus Biopharma Corp

Arbutus Biopharma Launches $230M Stock Buyback

Arbutus Biopharma announced the commencement of a modified Dutch Auction tender offer to purchase for cancellation up to $230M in value of its common shares at a price of not less than $5.00 and not more than $5.75 per share, less any applicable withholding taxes and without interest, on the terms and subject to the conditions described in the offer to purchase and accompanying issuer bid circular, dated August 24, the letter of transmittal and notice of guaranteed delivery. The offer begins August 24 and will expire at 5:00 p.m., New York City time, on September 29, unless extended or terminated by the company. The offer to purchase and bid circular, the letter of transmittal, the notice of guaranteed delivery and other tender offer materials are being filed with the SEC and the applicable Canadian securities regulatory authorities which may be accessed at www.sec.gov and www.sedarplus.ca, and will also be available at investor.arbutusbio.com. Arbutus also announced that on August 21, it obtained exemptive relief from the applicable Canadian securities regulatory authorities with respect to the proportionate take-up and extension requirements of the offer, the details of which can be found in the offer to purchase and bid circular. Arbutus also obtained exemptive relief from the SEC with respect to the proportionate tender feature included in the offer. The company intends to pay for the share repurchase with available cash on hand.

Major Averages Rise as Investors Tackle Yield Volatility

The major averages were broadly higher, ending the week on a high note as investors attempt to shake off a yield-driven selloff.Long-dated Treasury yields surged this week amid concerns about rising government debt, financing needs and persistent inflation, with the 30-year yield earlier reaching its highest level since 2007. Treasury Secretary Scott Bessent said the government could further expand its Treasury repurchases after this week's intervention, but yields remain near recent highs and investors remain concerned that buybacks do not address the underlying deficit and debt outlook.Meanwhile, oil and geopolitics are adding to inflation concerns. Diplomatic progress with Iran remains limited, while the U.S. is threatening tougher economic measures and Middle Eastern supply disruptions continue to support crude prices. That leaves investors weighing the prospect of renewed energy-driven inflation just as they are trying to determine the Federal Reserve's next move.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:BJ's Wholesaleprovided areport for Q2Ross Storesalso reported, increased its FY26 earnings outlook, and provided an upbeat earnings outlook for Q3Broadcomis in discussions with a group of lenders to raise over $60B in debt for an AI semiconductor financing deal that will benefit Anthropic and other firms,FedExand UPSwerefor Transportation Command contract modificationsThe Dutch Data Protection Authority is fining UberEUR825M, or about $966M, under European data protection rules for deactivating driver accounts through automated systems without properly telling them about it,2. WALL STREET CALLS:BMO Capitalcoverage of Nvidiawith an Outperform rating and $340 price targetEquifaxto Buy from Neutral at Rothschild & Co RedburnBairdParsonsto Outperform, says investor sentiment is lowTeradyneto Neutral at Baird on valuationJPMorganLimbachto Underweight from Neutral3. AROUND THE WEB:Appleis cutting jobs in multiple departments, Bloomberg reportsFugazi Research said in a short report that Aeva's"valuation is disconnected from the business the company actually reports"Poolside AI, an AI model-building startup, has struck a non-exclusive $6B licensing deal with Nvidia, plus a $1B investment at a $12B pre-money valuation, Newcomer saysSamsung Electronicsis expected to hold a board meeting and disclose the details of a shareholder return program that could be worth as much as $79B, Bloomberg reportsCitiis said to join Morgan Stanley, Goldman Sachs, and JPMorganas one of the banks working on bringing Anthropic to public markets, Bloomberg says4. MOVERS:O-I Glassincreased after Citithe stock to BuyArbutus Biopharmagained aftera modified "Dutch Auction" tender offer to repurchase up to $230M sharesCleveland-Cliffswas higher afterin Middletown WorksAmerican Electricfell after Morgan Stanleyits price target on the stockAlibabadeclined in New York after Citi and Bairdtheir price targets on the stock5. EARNINGS/GUIDANCE:The Buckle, with EPS lower year-over-yearKE Holdings, with EPS and revenue beating consensusFlowers Foodsand cut its guidance for FY26, with CEO Ryals McMullian commenting, "Our second quarter results reflect the continued challenges across the fresh packaged bread category"OSI Systems, with EPS beating consensusUbiquitireported year-over-year increases inINDEXES:The Dow rose 517.80, or 0.98%, to 53,277.01, the Nasdaq gained 113.29, or 0.43%, to 26,180.46, and the S&P 500 advanced 33.21, or 0.43%, to 7,674.37.